Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Papillary Serous”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00003560
What this trial is testing

Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Endometrial CancerFallopian Tube CancerOvarian Cancer+1 more
Herbert Irving Comprehensive Cancer Center 40
Large-scale testing (Phase 3)Study completedNCT00003749
What this trial is testing

Surgery With or Without Lymphadenectomy and Radiation Therapy in Treating Patients With Endometrial Cancer

Who this might be right for
Endometrial Cancer
Medical Research Council 2,300
Testing effectiveness (Phase 2)Active Not RecruitingNCT01116648
What this trial is testing

Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer

Who this might be right for
Fallopian Tube CarcinomaOvarian Endometrioid AdenocarcinomaOvarian High Grade Serous Adenocarcinoma+4 more
National Cancer Institute (NCI) 155
Testing effectiveness (Phase 2)Study completedNCT00231868
What this trial is testing

Radiation Therapy and Paclitaxel and Carboplatin in Patients With Uterine Papillary Serous Carcinoma

Who this might be right for
Uterine Cancer
Montefiore Medical Center 81
Testing effectiveness (Phase 2)Study completedNCT01010126
What this trial is testing

Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer

Who this might be right for
Adult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaEndometrial Serous Adenocarcinoma+42 more
National Cancer Institute (NCI) 252
Large-scale testing (Phase 3)Study completedNCT01672892
What this trial is testing

Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer

Who this might be right for
Cervical CancerEndometrial CancerGastrointestinal Complications+4 more
Radiation Therapy Oncology Group 289
Testing effectiveness (Phase 2)Looking for participantsNCT05150691
What this trial is testing

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

Who this might be right for
HER2-positive Advanced Solid Tumor
DualityBio Inc. 796
Early research (Phase 1)Study completedNCT01198184
What this trial is testing

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 and Temsirolimus in Treating Patients With Advanced Solid Tumors

Who this might be right for
Endometrial Papillary Serous CarcinomaRecurrent Endometrial CarcinomaRecurrent Renal Cell Cancer+5 more
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Ended earlyNCT00866723
What this trial is testing

Avastin in Patients With Epithelial Ovarian, Primary Peritoneal Serous or Fallopian Tube Cancer

Who this might be right for
Ovarian CancerPrimary Peritoneal Serous CancerFallopian Tube Cancer
Beth Israel Deaconess Medical Center 5
Not applicableStudy completedNCT02110498
What this trial is testing

Early Detection of Pancreatic Cystic Neoplasms

Who this might be right for
Pancreatic CystsIntraductal Papillary Mucinous NeoplasmPancreatic Mucinous-Cystic Neoplasm+2 more
Johns Hopkins University 3,000
Not applicableWithdrawnNCT00053235
What this trial is testing

Research Study in Patients With Advanced Ovarian Epithelial Cancer

Who this might be right for
Ovarian Serous CystadenocarcinomaOvarian Serous Surface Papillary AdenocarcinomaStage IIIA Ovarian Cancer+3 more
Gynecologic Oncology Group
Testing effectiveness (Phase 2)Active Not RecruitingNCT02978625
What this trial is testing

Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers

Who this might be right for
Anaplastic Large Cell Lymphoma, ALK-NegativeAnaplastic Large Cell Lymphoma, ALK-PositiveApocrine Carcinoma+36 more
National Cancer Institute (NCI) 68
Not applicableStudy completedNCT01836484
What this trial is testing

Diagnostic Accuracy of MRI, DWI MRI, FDG-PET/CT and FEC PET/CT in the Detection of Lymph Node Metastases in Surgically Staged Endometrial and Cervical Carcinoma

Who this might be right for
Surgically Staged Endometrial and Cervical CarcinomaCervical Cancer: Invasive Disease, FIGO Stage 1B1 or HigherEndometrial Cancer+3 more
Barts & The London NHS Trust 162
Testing effectiveness (Phase 2)Study completedNCT00664781
What this trial is testing

Rucaparib(CO-338;Formally Called AG-014699 or PF-0136738) in Treating Patients With Locally Advanced or Metastatic Breast Cancer or Advanced Ovarian Cancer

Who this might be right for
brca1 Mutation Carrierbrca2 Mutation CarrierBreast Cancer+1 more
Cancer Research UK 78
Testing effectiveness (Phase 2)Study completedNCT00052312
What this trial is testing

Doxorubicin and Cisplatin With or Without Paclitaxel in Treating Patients With Locally Advanced, Metastatic, and/or Relapsed Endometrial Cancer

Who this might be right for
Endometrial Cancer
European Organisation for Research and Treatment of Cancer - EORTC 141
Early research (Phase 1)WithdrawnNCT02050009
What this trial is testing

Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Ovarian Papillary Serous CarcinomaOvarian Serous CystadenocarcinomaRecurrent Fallopian Tube Cancer+3 more
Fox Chase Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT00003865
What this trial is testing

Toremifene in Treating Patients With Ovarian Cancer

Who this might be right for
Ovarian Cancer
George Washington University
Not applicableEnded earlyNCT02494388
What this trial is testing

Needle-based Confocal Laser Endomicroscopy on Pancreatic Cystic Lesions

Who this might be right for
Pancreatic CystsPancreatic Mucinous-Cystic NeoplasmIntraductal Papillary Mucinous Neoplasm+3 more
University of Medicine and Pharmacy Craiova 10
Testing effectiveness (Phase 2)Ended earlyNCT00653328
What this trial is testing

Ph II Atrasentan + DOXIL in Recurrent Ovarian/Fallopian/Peritoneal Serous Papillary Adenocarcinoma

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
Vanderbilt-Ingram Cancer Center 15
Large-scale testing (Phase 3)Study completedNCT00189553
What this trial is testing

Caelyx Plus Carboplatin Versus Paclitaxel Plus Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse

Who this might be right for
Ovarian CancerFallopian Tube Cancer
ARCAGY/ GINECO GROUP 976
Next Page